20.65 USD
▼-0.39-1.85%
盘后 20.50 0.00%
2026-11-20
市值
$405.26M
市盈率
—
EPS
-4.63
股息率
—
52 周区间
16.77 – 39.53
成交量
172.41K
Beta
0.51
目标价
71.00
52W 低 16.7752W 高 39.53
价格走势
公司简介
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPC...